🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The #DISCERNProject 3⃣rd Annual Meeting kicks off today in Brno 🇨🇿 ! 📍 Highlights include: ✅ Colorectal Cancer Workshop ✅ Discussions on novel risk factors, high-throughput biomonitoring, and cohort studies across Europe ✅ DISCERN's future impact 🔎 Stay tuned!

#MeetTheNominees for our Board! Today, get to know from 🇭🇷, representing IGET. She has over 20 years of experience treating digestive cancers. For her, DiCE is an opportunity to help extend these efforts on a broader scale. ➡️ digestivecancers.eu/nominees-board…

📽️ Watch our first video of the #KnowYourMarkers series! Understanding biomarkers is crucial for personalising mCRC treatment. Stay informed, get tested, and take control of your treatment journey. More on this👉 digestivecancers.eu/biomarkers-in-… #BiomarkersExplained #CancerAwareness

Last week, DiCE took part in the event #DigestiveHealth & #Obesity organised by my_UEG . 💬 DiCE’s Natasha Munch highlighted the gaps in survivorship care & called for stigma-free, personalised support in nutrition & mental health. 🤝Let's keep on cooperating to address this.

#MeetTheNominees for DiCE’s next Board of Directors! Today, we get to know Metka Glas from EuropaColon Slovenija. She is a caregiver coach & patient advocate, driven by personal experience & a strong commitment to the digestive cancer community. 👉 digestivecancers.eu/nominees-board…

The AIDA EU project is launching a free #Spanish-language webinar series to address the rise of gastric cancer cases in 🇪🇺. The first session focus is on the "Epidemiology of #GastricCancer". 🗓️ When: June 12 🕒 Moderator: Dr. Tania Fleitas 💻 digestivecancers-eu.zoom.us/webinar/regist… 🗣️ 🇪🇸

🗞️ What are the latest news on cancer research? Last week's #DISCERN Annual Meeting brought together leading healthcare experts and patient advocates to discuss crucial insights into colorectal, pancreatic, and kidney cancers. Read more▶️ linkedin.com/pulse/highligh…

DiCE CEO Zorana Maravic took part as a jury member at the #MadeWithPatients Awards 2025, a landmark event that recognises those transforming healthcare with and for patients. 👏Congratulations to all the wonderful 200 nominees for their energy, passion, and progress. #PEOF2025

#MeetTheNominees for DiCE’s next Board of Directors! We present the final candidate, Ségolène de RETZ from 🇫🇷, representing the Fondation ARCAD. Read more about her and other candidates 👉 digestivecancers.eu/nominees-board… #diceboard #DiCE #dicecandidates #digestivecancerseurope

Last week in Brussels 🇪🇺🇧🇪, DiCE participated in the #WorldCancerSeriesEurope, where over 80 speakers gathered to shape the future of cancer care across the continent. The event focused on inclusive access, data equity, and patient-centred outcomes, core pillars of DiCE’s work.

📣Meet the nominees for DiCE’s next Board of Directors. Each candidate represents a national organisation, brings experience in patient advocacy, and has a strong academic background. Each candidate is committed to strengthening DiCE’s mission. More info➡️ digestivecancers.eu/nominees-board…

📣#COR2ED has recently released a new, highly relevant micro-learning programme for healthcare professionals working in the hepatocellular carcinoma (#HCC) field to learn more about the complexity of choosing the proper treatment approach. ➡️ cor2ed.com/hcc-connect/pr… COR2ED

💬 As our CEO, Zorana Maravic, highlighted, no one should be forced to choose between cancer care & financial survival. #FinancialToxicity is a critical yet often overlooked part of the cancer journey. ESMO - Eur. Oncology expert consensus calls for action to ease the financial strain for🇪🇺.

#Sagittarius is a pioneering clinical trial testing a personalised approach to post-surgical colon cancer care. Using liquid biopsy to guide treatment aims to improve outcomes. 📰Subscribe for biannual updates, research insights, & patient perspectives➡️ linktr.ee/SAGITTARIUS_EU

"Today, I’m about 85% back to my old self. I still face mobility challenges and fatigue, but I’m grateful for each day. I am currently co-founding #PancreaticCancer 🇮🇪 to support and advocate for those affected by this disease." Read Pamela's story➡️digestivecancers.eu/patient-story/…

𝐇𝐞𝐥𝐩 𝐬𝐡𝐚𝐩𝐞 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐜𝐚𝐧𝐜𝐞𝐫 𝐜𝐚𝐫𝐞. #GUIDEMRD is rethinking how we use a simple blood test, ctDNA, to spot cancer’s return earlier and reduce unnecessary treatments. But to make it work in real life, we need your input➡️ surveymonkey.com/r/ZVSJGV6

DiCE joins 7⃣2⃣ patient organisations in supporting EURORDIS-Rare Diseases Europe and European Patients' Forum’s call to safeguard patient voting rights at the EU Medicines Agency.  #KeepPatientsVoting Read more➡️ digestivecancers.eu/wp-content/upl…

⏰One week to go! From 2–4 July, we’re gathering in Barcelona 🇪🇸 for 10th #DiCEMasterclass, a special edition marking 🔟 years of learning & advocacy. This annual event brings together representatives from our MOs to advocate for people affected by digestive cancers. #10Years

Are you a digestive cancer patient or carer? We’re running a short #study to compare educational summaries created by DiCE and AI🤖. Your feedback will help us improve how we communicate key information to support others like you. To learn more 📩 [email protected]

𝐓𝐡𝐞 𝟐𝟎𝟐𝟒 𝐃𝐢𝐂𝐄 𝐀𝐧𝐧𝐮𝐚𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐢𝐬 𝐨𝐮𝐭! It captures a year of action, spotlighting early-age onset cancers, the inaugural ENTERO Conference, EU research, awareness campaigns, and patient-centred advocacy. Read it here➡️ digestivecancers.us20.list-manage.com/track/click?u=…